APO Research

APO RESEARCH · REPORT

Genetically Modified Animal Models

Selected research

Market Structure

Global Genetically Modified Animal Models Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Genetically Modified Animal Models market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Genetically Modified Animal Models include ModelOrg, GemPharmatech, Cyagen Biosciences, Biocytogen, JOINN, China Environmental Technology and Bioenergy, Charles River, Taconic Biosciences and GenOway, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Genetically Modified Animal Models market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genetically Modified Animal Models and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genetically Modified Animal Models revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Genetically Modified Animal Models market size, projected growth trends, production technologies, key applications, and end-use industries.

Genetically Modified Animal Models Segment by Company

ModelOrg

GemPharmatech

Cyagen Biosciences

Biocytogen

JOINN

China Environmental Technology and Bioenergy

Charles River

Taconic Biosciences

GenOway

CLEA Japan

Ozgene

InVivo Biosystems

Harbour BioMed

PolyGene

Genetically Modified Animal Models Segment by Type

Rodents

Non-Human Primates

Zebrafish

Others

Genetically Modified Animal Models Segment by Application

Universities

Hospitals

Pharmaceutical Companies

Others

Genetically Modified Animal Models Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetically Modified Animal Models market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetically Modified Animal Models and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetically Modified Animal Models.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Genetically Modified Animal Models in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genetically Modified Animal Models industry.

Chapter 3: Detailed analysis of Genetically Modified Animal Models companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genetically Modified Animal Modelsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Genetically Modified Animal Models Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Rodents Table 3. Key Players of Non-Human Primates Table 4. Key Players of Zebrafish Table 3. Key Players of Others Table 4. Global Genetically Modified Animal Models Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Universities Table 6. Key Players of Hospitals Table 7. Key Players of Pharmaceutical Companies Table 8. Key Players of Others Table 9. Global Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Genetically Modified Animal Models Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Genetically Modified Animal Models Market Share by Region (2021-2026) Table 12. Global Genetically Modified Animal Models Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Genetically Modified Animal Models Market Share by Region (2027-2032) Table 14. Genetically Modified Animal Models Industry Trends Table 15. Genetically Modified Animal Models Industry Drivers Table 16. Genetically Modified Animal Models Industry Opportunities and Challenges Table 17. Genetically Modified Animal Models Industry Restraints Table 18. Global Genetically Modified Animal Models Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Genetically Modified Animal Models Revenue Market Share by Company (2021-2026) Table 20. Global Genetically Modified Animal Models Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Genetically Modified Animal Models Key Company Head Office and Area Served Table 22. Global Genetically Modified Animal Models Company, Product Type & Application Table 23. Global Genetically Modified Animal Models Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Genetically Modified Animal Models by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Genetically Modified Animal Models Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Genetically Modified Animal Models Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Genetically Modified Animal Models Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Genetically Modified Animal Models Revenue Market Share by Type (2021-2026) Table 30. Global Genetically Modified Animal Models Revenue Market Share by Type (2027-2032) Table 31. Global Genetically Modified Animal Models Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Genetically Modified Animal Models Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Genetically Modified Animal Models Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Genetically Modified Animal Models Revenue Market Share by Application (2021-2026) Table 35. Global Genetically Modified Animal Models Revenue Market Share by Application (2027-2032) Table 36. ModelOrg Company Information Table 37. ModelOrg Business Overview Table 38. ModelOrg Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. ModelOrg Genetically Modified Animal Models Product Portfolio Table 40. ModelOrg Recent Development Table 41. GemPharmatech Company Information Table 42. GemPharmatech Business Overview Table 43. GemPharmatech Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. GemPharmatech Genetically Modified Animal Models Product Portfolio Table 45. GemPharmatech Recent Development Table 46. Cyagen Biosciences Company Information Table 47. Cyagen Biosciences Business Overview Table 48. Cyagen Biosciences Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Cyagen Biosciences Genetically Modified Animal Models Product Portfolio Table 50. Cyagen Biosciences Recent Development Table 51. Biocytogen Company Information Table 52. Biocytogen Business Overview Table 53. Biocytogen Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Biocytogen Genetically Modified Animal Models Product Portfolio Table 55. Biocytogen Recent Development Table 56. JOINN Company Information Table 57. JOINN Business Overview Table 58. JOINN Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. JOINN Genetically Modified Animal Models Product Portfolio Table 60. JOINN Recent Development Table 61. China Environmental Technology and Bioenergy Company Information Table 62. China Environmental Technology and Bioenergy Business Overview Table 63. China Environmental Technology and Bioenergy Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. China Environmental Technology and Bioenergy Genetically Modified Animal Models Product Portfolio Table 65. China Environmental Technology and Bioenergy Recent Development Table 66. Charles River Company Information Table 67. Charles River Business Overview Table 68. Charles River Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Charles River Genetically Modified Animal Models Product Portfolio Table 70. Charles River Recent Development Table 71. Taconic Biosciences Company Information Table 72. Taconic Biosciences Business Overview Table 73. Taconic Biosciences Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Taconic Biosciences Genetically Modified Animal Models Product Portfolio Table 75. Taconic Biosciences Recent Development Table 76. GenOway Company Information Table 77. GenOway Business Overview Table 78. GenOway Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. GenOway Genetically Modified Animal Models Product Portfolio Table 80. GenOway Recent Development Table 81. CLEA Japan Company Information Table 82. CLEA Japan Business Overview Table 83. CLEA Japan Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. CLEA Japan Genetically Modified Animal Models Product Portfolio Table 85. CLEA Japan Recent Development Table 86. Ozgene Company Information Table 87. Ozgene Business Overview Table 88. Ozgene Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Ozgene Genetically Modified Animal Models Product Portfolio Table 90. Ozgene Recent Development Table 91. InVivo Biosystems Company Information Table 92. InVivo Biosystems Business Overview Table 93. InVivo Biosystems Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. InVivo Biosystems Genetically Modified Animal Models Product Portfolio Table 95. InVivo Biosystems Recent Development Table 96. Harbour BioMed Company Information Table 97. Harbour BioMed Business Overview Table 98. Harbour BioMed Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Harbour BioMed Genetically Modified Animal Models Product Portfolio Table 100. Harbour BioMed Recent Development Table 101. PolyGene Company Information Table 102. PolyGene Business Overview Table 103. PolyGene Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. PolyGene Genetically Modified Animal Models Product Portfolio Table 105. PolyGene Recent Development Table 106. North America Genetically Modified Animal Models Market Size by Type (2021-2026) & (US$ Million) Table 107. North America Genetically Modified Animal Models Market Size by Type (2027-2032) & (US$ Million) Table 108. North America Genetically Modified Animal Models Market Size by Application (2021-2026) & (US$ Million) Table 109. North America Genetically Modified Animal Models Market Size by Application (2027-2032) & (US$ Million) Table 110. North America Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Genetically Modified Animal Models Market Size by Country (2021-2026) Table 112. North America Genetically Modified Animal Models Market Size by Country (2027-2032) Table 113. Europe Genetically Modified Animal Models Market Size by Type (2021-2026) & (US$ Million) Table 114. Europe Genetically Modified Animal Models Market Size by Type (2027-2032) & (US$ Million) Table 115. Europe Genetically Modified Animal Models Market Size by Application (2021-2026) & (US$ Million) Table 116. Europe Genetically Modified Animal Models Market Size by Application (2027-2032) & (US$ Million) Table 117. Europe Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Genetically Modified Animal Models Market Size by Country (2021-2026) Table 119. Europe Genetically Modified Animal Models Market Size by Country (2027-2032) Table 120. China Genetically Modified Animal Models Market Size by Type (2021-2026) & (US$ Million) Table 121. China Genetically Modified Animal Models Market Size by Type (2027-2032) & (US$ Million) Table 122. China Genetically Modified Animal Models Market Size by Application (2021-2026) & (US$ Million) Table 123. China Genetically Modified Animal Models Market Size by Application (2027-2032) & (US$ Million) Table 124. Asia Genetically Modified Animal Models Market Size by Type (2021-2026) & (US$ Million) Table 125. Asia Genetically Modified Animal Models Market Size by Type (2027-2032) & (US$ Million) Table 126. Asia Genetically Modified Animal Models Market Size by Application (2021-2026) & (US$ Million) Table 127. Asia Genetically Modified Animal Models Market Size by Application (2027-2032) & (US$ Million) Table 128. Asia Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Asia Genetically Modified Animal Models Market Size by Country (2021-2026) Table 130. Asia Genetically Modified Animal Models Market Size by Country (2027-2032) Table 131. South America, Middle East & Africa Genetically Modified Animal Models Market Size by Type (2021-2026) & (US$ Million) Table 132. South America, Middle East & Africa Genetically Modified Animal Models Market Size by Type (2027-2032) & (US$ Million) Table 133. South America, Middle East & Africa Genetically Modified Animal Models Market Size by Application (2021-2026) & (US$ Million) Table 134. South America, Middle East & Africa Genetically Modified Animal Models Market Size by Application (2027-2032) & (US$ Million) Table 135. South America, Middle East & Africa Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. South America, Middle East & Africa Genetically Modified Animal Models Market Size by Country (2021-2026) Table 137. South America, Middle East & Africa Genetically Modified Animal Models Market Size by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Genetically Modified Animal Models Product Image Figure 2. Global Genetically Modified Animal Models Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Genetically Modified Animal Models Market Share by Type: 2025 VS 2032 Figure 4. Rodents Image Figure 5. Non-Human Primates Image Figure 6. Zebrafish Image Figure 7. Others Image Figure 8. Global Genetically Modified Animal Models Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Genetically Modified Animal Models Market Share by Application: 2025 VS 2032 Figure 10. Universities Image Figure 11. Hospitals Image Figure 12. Pharmaceutical Companies Image Figure 13. Others Image Figure 14. Global Genetically Modified Animal Models Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 16. Global Genetically Modified Animal Models Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Genetically Modified Animal Models Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Genetically Modified Animal Models Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Genetically Modified Animal Models Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Genetically Modified Animal Models Revenue Market Share by Type (2021-2032) Figure 23. Global Genetically Modified Animal Models Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Genetically Modified Animal Models Revenue Market Share by Application (2021-2032) Figure 25. North America Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 26. North America Genetically Modified Animal Models Market Share by Type (2021-2032) Figure 27. North America Genetically Modified Animal Models Market Share by Application (2021-2032) Figure 28. North America Genetically Modified Animal Models Market Share by Country (2021-2032) Figure 29. United States Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 30. Canada Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 32. Europe Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 33. Europe Genetically Modified Animal Models Market Share by Type (2021-2032) Figure 34. Europe Genetically Modified Animal Models Market Share by Application (2021-2032) Figure 35. Europe Genetically Modified Animal Models Market Share by Country (2021-2032) Figure 36. Germany Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 37. France Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 39. Italy Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 40. Russia Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 42. China Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 43. China Genetically Modified Animal Models Market Share by Type (2021-2032) Figure 44. China Genetically Modified Animal Models Market Share by Application (2021-2032) Figure 45. Asia Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 46. Asia Genetically Modified Animal Models Market Share by Type (2021-2032) Figure 47. Asia Genetically Modified Animal Models Market Share by Application (2021-2032) Figure 48. Asia Genetically Modified Animal Models Market Share by Country (2021-2032) Figure 49. Japan Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 53. India Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 54. Australia Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Genetically Modified Animal Models Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Genetically Modified Animal Models Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Genetically Modified Animal Models Market Share by Country (2021-2032) Figure 59. Brazil Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 64. UAE Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 66. Chile Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Rodents
  • Non-Human Primates
  • Zebrafish
  • Others
Applications
  • Universities
  • Hospitals
  • Pharmaceutical Companies
  • Others
Companies covered
  • ModelOrg
  • GemPharmatech
  • Cyagen Biosciences
  • Biocytogen
  • JOINN
  • China Environmental Technology and Bioenergy
  • Charles River
  • Taconic Biosciences
  • GenOway
  • CLEA Japan
  • Ozgene
  • InVivo Biosystems
  • Harbour BioMed
  • PolyGene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Genetically Modified Animal Models Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Rodents
  5. 1.2.3 Non-Human Primates
  6. 1.2.4 Zebrafish
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Genetically Modified Animal Models Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Universities
  11. 1.3.3 Hospitals
  12. 1.3.4 Pharmaceutical Companies
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Genetically Modified Animal Models Growth Trends by Region
  16. 1.5.1 Global Genetically Modified Animal Models Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Genetically Modified Animal Models Market Size by Region (2021-2026)
  18. 1.5.3 Genetically Modified Animal Models Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Genetically Modified Animal Models Market Dynamics
  1. 2.1 Genetically Modified Animal Models Industry Trends
  2. 2.2 Genetically Modified Animal Models Industry Drivers
  3. 2.3 Genetically Modified Animal Models Industry Opportunities and Challenges
  4. 2.4 Genetically Modified Animal Models Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Genetically Modified Animal Models Revenue by Company (2021-2026)
  2. 3.2 Global Genetically Modified Animal Models Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Genetically Modified Animal Models Key Company Head office and Area Served
  4. 3.4 Global Genetically Modified Animal Models Company, Product Type & Application
  5. 3.5 Global Genetically Modified Animal Models Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Genetically Modified Animal Models Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Genetically Modified Animal Models Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Genetically Modified Animal Models Tier 1, Tier 2, and Tier 3
4 Genetically Modified Animal Models Market by Type
  1. 4.1 Global Genetically Modified Animal Models Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Genetically Modified Animal Models Market Size by Type (2021-2032)
  3. 4.3 Global Genetically Modified Animal Models Market Size Share by Type (2021-2032)
5 Genetically Modified Animal Models Market by Application
  1. 5.1 Global Genetically Modified Animal Models Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Genetically Modified Animal Models Market Size by Application (2021-2032)
  3. 5.3 Global Genetically Modified Animal Models Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 ModelOrg
  2. 6.1.1 ModelOrg Company Information
  3. 6.1.2 ModelOrg Business Overview
  4. 6.1.3 ModelOrg Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 ModelOrg Genetically Modified Animal Models Product Portfolio
  6. 6.1.5 ModelOrg Recent Developments
  7. 6.2 GemPharmatech
  8. 6.2.1 GemPharmatech Company Information
  9. 6.2.2 GemPharmatech Business Overview
  10. 6.2.3 GemPharmatech Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 GemPharmatech Genetically Modified Animal Models Product Portfolio
  12. 6.2.5 GemPharmatech Recent Developments
  13. 6.3 Cyagen Biosciences
  14. 6.3.1 Cyagen Biosciences Company Information
  15. 6.3.2 Cyagen Biosciences Business Overview
  16. 6.3.3 Cyagen Biosciences Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Cyagen Biosciences Genetically Modified Animal Models Product Portfolio
  18. 6.3.5 Cyagen Biosciences Recent Developments
  19. 6.4 Biocytogen
  20. 6.4.1 Biocytogen Company Information
  21. 6.4.2 Biocytogen Business Overview
  22. 6.4.3 Biocytogen Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Biocytogen Genetically Modified Animal Models Product Portfolio
  24. 6.4.5 Biocytogen Recent Developments
  25. 6.5 JOINN
  26. 6.5.1 JOINN Company Information
  27. 6.5.2 JOINN Business Overview
  28. 6.5.3 JOINN Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 JOINN Genetically Modified Animal Models Product Portfolio
  30. 6.5.5 JOINN Recent Developments
  31. 6.6 China Environmental Technology and Bioenergy
  32. 6.6.1 China Environmental Technology and Bioenergy Company Information
  33. 6.6.2 China Environmental Technology and Bioenergy Business Overview
  34. 6.6.3 China Environmental Technology and Bioenergy Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 China Environmental Technology and Bioenergy Genetically Modified Animal Models Product Portfolio
  36. 6.6.5 China Environmental Technology and Bioenergy Recent Developments
  37. 6.7 Charles River
  38. 6.7.1 Charles River Company Information
  39. 6.7.2 Charles River Business Overview
  40. 6.7.3 Charles River Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Charles River Genetically Modified Animal Models Product Portfolio
  42. 6.7.5 Charles River Recent Developments
  43. 6.8 Taconic Biosciences
  44. 6.8.1 Taconic Biosciences Company Information
  45. 6.8.2 Taconic Biosciences Business Overview
  46. 6.8.3 Taconic Biosciences Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Taconic Biosciences Genetically Modified Animal Models Product Portfolio
  48. 6.8.5 Taconic Biosciences Recent Developments
  49. 6.9 GenOway
  50. 6.9.1 GenOway Company Information
  51. 6.9.2 GenOway Business Overview
  52. 6.9.3 GenOway Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 GenOway Genetically Modified Animal Models Product Portfolio
  54. 6.9.5 GenOway Recent Developments
  55. 6.10 CLEA Japan
  56. 6.10.1 CLEA Japan Company Information
  57. 6.10.2 CLEA Japan Business Overview
  58. 6.10.3 CLEA Japan Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 CLEA Japan Genetically Modified Animal Models Product Portfolio
  60. 6.10.5 CLEA Japan Recent Developments
  61. 6.11 Ozgene
  62. 6.11.1 Ozgene Company Information
  63. 6.11.2 Ozgene Business Overview
  64. 6.11.3 Ozgene Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Ozgene Genetically Modified Animal Models Product Portfolio
  66. 6.11.5 Ozgene Recent Developments
  67. 6.12 InVivo Biosystems
  68. 6.12.1 InVivo Biosystems Company Information
  69. 6.12.2 InVivo Biosystems Business Overview
  70. 6.12.3 InVivo Biosystems Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 InVivo Biosystems Genetically Modified Animal Models Product Portfolio
  72. 6.12.5 InVivo Biosystems Recent Developments
  73. 6.13 Harbour BioMed
  74. 6.13.1 Harbour BioMed Company Information
  75. 6.13.2 Harbour BioMed Business Overview
  76. 6.13.3 Harbour BioMed Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Harbour BioMed Genetically Modified Animal Models Product Portfolio
  78. 6.13.5 Harbour BioMed Recent Developments
  79. 6.14 PolyGene
  80. 6.14.1 PolyGene Company Information
  81. 6.14.2 PolyGene Business Overview
  82. 6.14.3 PolyGene Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 PolyGene Genetically Modified Animal Models Product Portfolio
  84. 6.14.5 PolyGene Recent Developments
7 North America
  1. 7.1 North America Genetically Modified Animal Models Market Size (2021-2032)
  2. 7.2 North America Genetically Modified Animal Models Market Size by Type
  3. 7.2.1 North America Genetically Modified Animal Models Market Size by Type (2021-2026)
  4. 7.2.2 North America Genetically Modified Animal Models Market Size by Type (2027-2032)
  5. 7.2.3 North America Genetically Modified Animal Models Market Share by Type (2021-2032)
  6. 7.3 North America Genetically Modified Animal Models Market Size by Application
  7. 7.3.1 North America Genetically Modified Animal Models Market Size by Application (2021-2026)
  8. 7.3.2 North America Genetically Modified Animal Models Market Size by Application (2027-2032)
  9. 7.3.3 North America Genetically Modified Animal Models Market Share by Application (2021-2032)
  10. 7.4 North America Genetically Modified Animal Models Market Size by Country
  11. 7.4.1 North America Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Genetically Modified Animal Models Market Size by Country (2021-2026)
  13. 7.4.3 North America Genetically Modified Animal Models Market Size by Country (2027-2032)
  14. 7.4.4 North America Genetically Modified Animal Models Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Genetically Modified Animal Models Market Size (2021-2032)
  2. 8.2 Europe Genetically Modified Animal Models Market Size by Type
  3. 8.2.1 Europe Genetically Modified Animal Models Market Size by Type (2021-2026)
  4. 8.2.2 Europe Genetically Modified Animal Models Market Size by Type (2027-2032)
  5. 8.2.3 Europe Genetically Modified Animal Models Market Share by Type (2021-2032)
  6. 8.3 Europe Genetically Modified Animal Models Market Size by Application
  7. 8.3.1 Europe Genetically Modified Animal Models Market Size by Application (2021-2026)
  8. 8.3.2 Europe Genetically Modified Animal Models Market Size by Application (2027-2032)
  9. 8.3.3 Europe Genetically Modified Animal Models Market Share by Application (2021-2032)
  10. 8.4 Europe Genetically Modified Animal Models Market Size by Country
  11. 8.4.1 Europe Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Genetically Modified Animal Models Market Size by Country (2021-2026)
  13. 8.4.3 Europe Genetically Modified Animal Models Market Size by Country (2027-2032)
  14. 8.4.4 Europe Genetically Modified Animal Models Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Genetically Modified Animal Models Market Size (2021-2032)
  2. 9.2 China Genetically Modified Animal Models Market Size by Type
  3. 9.2.1 China Genetically Modified Animal Models Market Size by Type (2021-2026)
  4. 9.2.2 China Genetically Modified Animal Models Market Size by Type (2027-2032)
  5. 9.2.3 China Genetically Modified Animal Models Market Share by Type (2021-2032)
  6. 9.3 China Genetically Modified Animal Models Market Size by Application
  7. 9.3.1 China Genetically Modified Animal Models Market Size by Application (2021-2026)
  8. 9.3.2 China Genetically Modified Animal Models Market Size by Application (2027-2032)
  9. 9.3.3 China Genetically Modified Animal Models Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Genetically Modified Animal Models Market Size (2021-2032)
  2. 10.2 Asia Genetically Modified Animal Models Market Size by Type
  3. 10.2.1 Asia Genetically Modified Animal Models Market Size by Type (2021-2026)
  4. 10.2.2 Asia Genetically Modified Animal Models Market Size by Type (2027-2032)
  5. 10.2.3 Asia Genetically Modified Animal Models Market Share by Type (2021-2032)
  6. 10.3 Asia Genetically Modified Animal Models Market Size by Application
  7. 10.3.1 Asia Genetically Modified Animal Models Market Size by Application (2021-2026)
  8. 10.3.2 Asia Genetically Modified Animal Models Market Size by Application (2027-2032)
  9. 10.3.3 Asia Genetically Modified Animal Models Market Share by Application (2021-2032)
  10. 10.4 Asia Genetically Modified Animal Models Market Size by Country
  11. 10.4.1 Asia Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Genetically Modified Animal Models Market Size by Country (2021-2026)
  13. 10.4.3 Asia Genetically Modified Animal Models Market Size by Country (2027-2032)
  14. 10.4.4 Asia Genetically Modified Animal Models Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Genetically Modified Animal Models Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Genetically Modified Animal Models Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Genetically Modified Animal Models Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Genetically Modified Animal Models Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research